Cost effectiveness

Cost-Effectiveness trials

A cost-effectiveness RCT integrates economic evaluation alongside clinical outcomes to assess whether an intervention provides good value for its cost. It combines health outcomes and resource use to inform healthcare decision-making.

1. Define the Research Question

• Primary focus: Is the intervention cost-effective compared to the control?
• Specify the perspective of the analysis:
  • Healthcare system
  • Societal
  • Payer or patient
• Example: Is Drug A more cost-effective than Drug B in reducing hospital readmissions?

2. Choose the Appropriate Study Design

• Parallel-Group RCT: Standard design where individuals are randomized to intervention or control.
• Cluster RCT: Ideal for health system-level or practice-level interventions.

3. Define the Outcome Measures

Clinical Outcomes

• Primary clinical outcomes (e.g., symptom reduction, mortality, quality of life).

Economic Outcomes

• Costs
  • Direct: Medications, hospital visits, tests, diagnostics.
  • Indirect: Lost productivity, travel costs, caregiver time.
• Effectiveness
  • Use composite measures such as:
    • Quality-Adjusted Life Years (QALYs)
    • Disability-Adjusted Life Years (DALYs)
• Incremental Cost-Effectiveness Ratio (ICER)

ICER = (Cost of Intervention – Cost of Control) ÷ (Effectiveness of Intervention – Effectiveness of Control)

4. Sample Size Calculation

• Account for variability in both clinical and cost data.
• Ensure the trial is powered to detect differences in cost-effectiveness.
• Larger sample sizes are often needed due to high cost variability.

5. Collect and Track Data

• Clinical Data: Standard RCT outcome collection.
• Cost Data: Use:
  • Hospital billing data
  • Insurance claims
  • Self-reported cost/resource use questionnaires
• Quality of Life Data:
  • Tools like EQ-5D, SF-36, or HUI for QALY estimation.

6. Randomization and Blinding

• Use proper randomization to eliminate bias in both outcomes and costs.
• Blinding is ideal but may not apply to cost data.

7. Plan the Economic Evaluation

• Perspective: Define it clearly (e.g., societal vs. healthcare system).
• Time Horizon:
  • Short-term (trial duration)
  • Long-term (lifetime, using modeling)
• Discounting:
  • Apply annual discount rates (e.g., 3–5%) for long-term projections.

8. Statistical and Economic Analysis

• Clinical Analysis: Intention-to-treat or per-protocol.
• Cost Analysis:
  • Calculate and compare mean costs.
  • Use bootstrapping to estimate confidence intervals.
• Cost-Effectiveness Analysis (CEA):
  • Present ICER values.
  • Plot results on the cost-effectiveness plane.
• Cost-Effectiveness Acceptability Curve (CEAC):
  • Shows probability that the intervention is cost-effective at varying willingness-to-pay thresholds.

9. Address Uncertainty

• Sensitivity Analysis:
  • Deterministic: Change one input at a time.
  • Probabilistic: Simulate variability across multiple parameters using distributions.
• Use Monte Carlo simulations for probabilistic models.

10. Reporting and Dissemination

• Follow the CHEERS (Consolidated Health Economic Evaluation Reporting Standards) guidelines.
• Report both clinical and economic findings transparently.

Example Study Design

Research Question: Is a digital health intervention for diabetes management cost-effective compared to standard care?

• Design: Parallel-group RCT
• Clinical Outcomes: HbA1c reduction, QALYs
• Cost Data: Clinic visits, medication use, hospitalization, device costs
• Analysis: Calculate ICER (cost per QALY gained)

Conclusion

Cost-effectiveness trials help determine whether healthcare interventions provide good value. By integrating economic and clinical outcomes, these trials inform resource allocation and policy decisions in healthcare systems.

---

Bibliography

1. Drummond MF, Sculpher MJ, Claxton K, Stoddart GL, Torrance GW. Methods for the Economic Evaluation of Health Care Programmes. 4th ed. Oxford University Press; 2015.
2. Neumann PJ, Sanders GD, Russell LB, Siegel JE, Ganiats TG, editors. Cost-Effectiveness in Health and Medicine. 2nd ed. Oxford University Press; 2017.
3. Glick HA, Doshi JA, Sonnad SS, Polsky D. Economic Evaluation in Clinical Trials. 2nd ed. Oxford University Press; 2014.
4. Willan AR, Briggs AH. Statistical Analysis of Cost-Effectiveness Data. Chichester: Wiley; 2006.
5. Ramsey SD, Willke RJ, Glick H, et al. Cost-effectiveness analysis alongside clinical trials II: an ISPOR Good Research Practices Task Force report. Value in Health. 2015;18(2):161–172.

---

Adapted for educational use. Please cite relevant trial methodology sources when using this material in research or teaching.